115 related articles for article (PubMed ID: 1834673)
21. Quantitation and characterization of gamma-interferon receptors on human tumor cells.
Ucer U; Bartsch H; Scheurich P; Berkovic D; Ertel C; Pfizenmaier K
Cancer Res; 1986 Oct; 46(10):5339-43. PubMed ID: 2944578
[TBL] [Abstract][Full Text] [Related]
22. Purification and biochemical characterization of a soluble human interferon gamma receptor expressed in Escherichia coli.
Fountoulakis M; Juranville JF; Stüber D; Weibel EK; Garotta G
J Biol Chem; 1990 Aug; 265(22):13268-75. PubMed ID: 2142945
[TBL] [Abstract][Full Text] [Related]
23. Corticosteroids enhance the binding of recombinant interferon-gamma to cultured human monocytes.
Strickland RW; Wahl LM; Finbloom DS
J Immunol; 1986 Sep; 137(5):1577-80. PubMed ID: 2943796
[TBL] [Abstract][Full Text] [Related]
24. A 25-kDa stretch of the extracellular domain of the human interferon gamma receptor is required for full ligand binding capacity.
Fountoulakis M; Lahm HW; Maris A; Friedlein A; Manneberg M; Stueber D; Garotta G
J Biol Chem; 1991 Aug; 266(23):14970-7. PubMed ID: 1831199
[TBL] [Abstract][Full Text] [Related]
25. Glycosylation of the human interferon-gamma receptor. N-linked carbohydrates contribute to structural heterogeneity and are required for ligand binding.
Fischer T; Thoma B; Scheurich P; Pfizenmaier K
J Biol Chem; 1990 Jan; 265(3):1710-7. PubMed ID: 2136857
[TBL] [Abstract][Full Text] [Related]
26. Two molecular forms of the human interferon-gamma receptor. Ligand binding, internalization, and down-regulation.
Fischer DG; Novick D; Orchansky P; Rubinstein M
J Biol Chem; 1988 Feb; 263(6):2632-7. PubMed ID: 2963815
[TBL] [Abstract][Full Text] [Related]
27. Monocyte-derived CD40 expression is regulated by interferon-γ/interferon-γ receptor-1 pathway when acting as a bridge during their interaction with T cells and allogeneic endothelial cells.
Zhu LM; Fang YS; Sun ZG; Yu LZ; Xu H
Transplant Proc; 2012 May; 44(4):996-8. PubMed ID: 22564607
[TBL] [Abstract][Full Text] [Related]
28. Culture of human monocytes with granulocyte-macrophage colony-stimulating factor results in enhancement of IFN-gamma receptors but suppression of IFN-gamma-induced expression of the gene IP-10.
Finbloom DS; Larner AC; Nakagawa Y; Hoover DL
J Immunol; 1993 Mar; 150(6):2383-90. PubMed ID: 8450219
[TBL] [Abstract][Full Text] [Related]
29. Differential modulation of two interferon-alpha binding proteins on a human lymphoblastoid cell line.
Faltynek CR; Princler GL; Schwabe M
Cytokine; 1991 Nov; 3(6):627-35. PubMed ID: 1838703
[TBL] [Abstract][Full Text] [Related]
30. Use of synthetic peptides to identify an N-terminal epitope on mouse gamma interferon that may be involved in function.
Magazine HI; Carter JM; Russell JK; Torres BA; Dunn BM; Johnson HM
Proc Natl Acad Sci U S A; 1988 Feb; 85(4):1237-41. PubMed ID: 2448795
[TBL] [Abstract][Full Text] [Related]
31. Binding of 125I-gamma interferon to cultured human keratinocytes.
Nickoloff BJ
J Invest Dermatol; 1987 Aug; 89(2):132-5. PubMed ID: 2439610
[TBL] [Abstract][Full Text] [Related]
32. Demonstration of the presence of a specific interferon-gamma receptor on murine astrocyte cell surface.
Rubio N; de Felipe C
J Neuroimmunol; 1991 Dec; 35(1-3):111-7. PubMed ID: 1835463
[TBL] [Abstract][Full Text] [Related]
33. Agonist and antagonist effects of interferon alpha and beta on activation of human macrophages. Two classes of interferon gamma receptors and blockade of the high-affinity sites by interferon alpha or beta.
Yoshida R; Murray HW; Nathan CF
J Exp Med; 1988 Mar; 167(3):1171-85. PubMed ID: 2965208
[TBL] [Abstract][Full Text] [Related]
34. Purification of human gamma interferon receptors by sequential affinity chromatography on immobilized monoclonal antireceptor antibodies and human gamma interferon.
Aguet M; Merlin G
J Exp Med; 1987 Apr; 165(4):988-99. PubMed ID: 2435837
[TBL] [Abstract][Full Text] [Related]
35. Characterization of human interferon-gamma receptor purified from placenta.
Stefanos S; Ahn YH; Pestka S
J Interferon Res; 1989 Dec; 9(6):719-30. PubMed ID: 2532663
[TBL] [Abstract][Full Text] [Related]
36. Demonstration and partial characterization of the interferon-gamma receptor on human B lymphocytes.
Nakagawa T; Nakagawa N; Delsing GA; Volkman D; Kehrl JH
J Cell Biochem; 1989 Aug; 40(4):417-30. PubMed ID: 2528554
[TBL] [Abstract][Full Text] [Related]
37. Preparation of 32P-labeled murine immune interferon and its binding to the mouse immune interferon receptor.
Langer JA; Rashidbaigi A; Pestka S
J Biol Chem; 1986 Jul; 261(21):9801-4. PubMed ID: 3015908
[TBL] [Abstract][Full Text] [Related]
38. An active covalently linked dimer of human interferon-gamma. Subunit orientation in the native protein.
Lunn CA; Davies L; Dalgarno D; Narula SK; Zavodny PJ; Lundell D
J Biol Chem; 1992 Sep; 267(25):17920-4. PubMed ID: 1387644
[TBL] [Abstract][Full Text] [Related]
39. Interferon-gamma induces receptor dimerization in solution and on cells.
Greenlund AC; Schreiber RD; Goeddel DV; Pennica D
J Biol Chem; 1993 Aug; 268(24):18103-10. PubMed ID: 8349687
[TBL] [Abstract][Full Text] [Related]
40. Enrichment and initial characterization of the solubilized receptor for mouse gamma interferon.
Hayes MP; Russell SW; Trotta PP; Basu M
Biochem Biophys Res Commun; 1988 Feb; 150(3):1096-105. PubMed ID: 2963631
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
